RegisterLogin

TMLB-C16

CAT: 0804-HY-177796-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-177796-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
TMLB-C16 is a potent and orally active B3GAT3 inhibitor with a KD of 3.962 μM. TMLB-C16 suppresses proliferation and migration, and induces cell cycle arrest and apoptosis in MHCC-97H (IC50 = 6.53 μM) and HCCLM3 cells (IC50 = 6.22 μM) . TMLB-C16 inhibits tumor growth in both MHCC-97H and HCCLM3 xenograft tumor mouse models without causing obvious toxicity. TMLB-C16 can be used for hepatocellular carcinoma research[1].
CAS Number
[2923531-50-2]
UNSPSC
12352005
Target
Apoptosis; Caspase; CDK; PARP
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(C1=CC2=C(NC=C2C(C(NC3C(N(CC3)C4=CC=C(C)C=C4Cl)=O)=O)=O)C=C1)OC
Molecular Formula
C23H20ClN3O5
Molecular Weight
453.88
References & Citations
[1]Yin H, et al. Discovery of Novel 2-Oxoacetamide Derivatives as B3GAT3 Inhibitors for the Treatment of Hepatocellular Carcinoma. J Med Chem. 2024 Jul 11;67 (13) :10743-10773.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-W590669-01C16-Dihydroceramide
HY-168764-01C16 Galactosylceramide
HY-108635-01C16-PAF
HY-116258-01C16 Ceramide (d16:1, C16:0)
HY-13977A-01PKR-IN-C16
HY-100354-01C16-Ceramide
HY-P11301C16-pHD108
HY-116258SC16 Ceramide-d7 (d16:1, C16:0)
HY-147755C16-K-cBB1
HY-144005BC16 PEG5000 Ceramide

Alternative Products

CatalogName
MBS808197-01C16
268065-01C16-Ceramide
TP3842-01C16-pHD108
MBS565687-01C16 Ceramide
MBS5802209PAF (C16)
T203217-01C16 Ceramide (d16:1, C16:0)
T16550-01PKR-IN-C16
TRC-S680725-500MGC16-Sphingosine
T203258-01C16 Galactosylceramide
C262910C16 Dihydroceramide

Popular Products